[Form 4] Graco Inc Insider Trading Activity
Graco Inc. insider reported option exercise, share sale, and dividend reinvestment activity. A nonemployee director exercised 6,000 options at an exercise price of $26.68 and acquired 6,000 shares through that exercise. The reporting person also sold 6,000 shares at a weighted-average price of $85.80, with sale prices in the $85.72–$85.88 range. The reporting person’s post-transaction beneficial ownership is reported as 45,978.7 shares. The filing notes that some shares were acquired via the company’s dividend reinvestment plan and that the option grant was issued under the company’s stock incentive plan and is fully exercisable.
- Transparent disclosure of option exercise, sale transaction prices (range provided), and dividend reinvestment acquisitions
- Option grant described as fully exercisable under the company’s stock incentive plan, consistent with standard director compensation
- Director sold 6,000 shares, which represents a dilution of insider holdings and may be perceived as insider liquidity
- Weighted-average sale price suggests disposition at market levels rather than retention, which some investors may view negatively
Insights
TL;DR: Routine director option exercise with concurrent sale; neutral to limited market impact.
The director exercised a fully vested nonqualified option and immediately sold an equal number of shares, a common liquidity action following option exercise or compensation vesting. The sale size (6,000 shares) should be evaluated relative to total outstanding shares for market impact; the form reports a weighted-average sale price in the mid-$85 range. The transaction is disclosed under Section 16 reporting rules and includes shares acquired via the dividend reinvestment plan, which is administrative and non-indicative of corporate performance shifts.
TL;DR: Compensation-related issuance and immediate disposition documented; governance disclosure appears compliant.
The option was granted pursuant to the company’s equity incentive plan and is described as fully exercisable and exempt under Rule 16b-3, indicating standard director compensation treatment. The filer disclosed the dividend reinvestment acquisition and provided a price range for the sale, offering transparency. There are no indications in the filing of related-party conflicts or unusual transfer mechanisms.